I agree that this site is using cookies. You can find further informations here.
X
Hlavacek, Patrick
92  results:
Search for persons X
?
1

Assessment of algorithms for identifying patients with trip..:

Sinyavskaya, Liliya ; Meche, Aster ; Faucher, Ariane...
Current Medical Research and Opinion.  40 (2024)  5 - p. 789-801 , 2024
Link: https://doi.org/10.1080/..
 
?
2

A matching-adjusted indirect comparison of the efficacy of ..:

Mol, Isha ; Hu, Yannan ; LeBlanc, Thomas W....
Leukemia & Lymphoma.  65 (2024)  5 - p. 660-668 , 2024
Link: https://doi.org/10.1080/..
 
?
3

Elranatamab efficacy in MagnetisMM-3 compared with real-wor..:

Costa, Luciano J ; LeBlanc, Thomas W ; Tesch, Hans...
Future Oncology.  , 2024
Link: https://doi.org/10.2217/..
 
?
4

P-248 Real-world outcomes of triple-class exposed multiple ..:

Meche, Aster ; Rondeau, Felix ; Faucher, Ariane...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S172-S173 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Comparing g-computation, propensity score-based weighting, ..:

Ren, Jinma ; Cislo, Paul ; Cappelleri, Joseph C...
BMC Medical Research Methodology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
6

P957: AN INDIRECT COMPARISON OF ELRANATAMAB'S (ELRA) OBJECT..:

Costa, Luciano ; Leblanc, Thomas W ; Tesch, Hans...
HemaSphere.  7 (2023)  S3 - p. e343009d , 2023
Link: https://doi.org/10.1097/..
 
?
7

Contemporary prevalence estimates of undiagnosed and diagno..:

Turakhia, Mintu P. ; Guo, Jennifer D. ; Keshishian, Allison...
Clinical Cardiology.  46 (2023)  5 - p. 484-493 , 2023
Link: https://doi.org/10.1002/..
 
?
8

P-249 The association between age, performance status, frai..:

Meche, Aster ; Rondeau, Felix ; Johnson, Sarasa...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S173 , 2023
Link: https://doi.org/10.1016/..
 
?
9

PB2100: REAL-WORLD TREATMENT PATTERNS OF TRIPLE-CLASS REFRA..:

Guillaume, Xavier ; Horchi, Dahbia ; Gomez, Jorge...
HemaSphere.  7 (2023)  S3 - p. e8647215 , 2023
Link: https://doi.org/10.1097/..
 
?
10

Warfarin Time in Therapeutic INR Range and Direct Oral Anti..:

Din, Natasha ; Fan, Jun ; Schmitt, Susan...
Clinical and Applied Thrombosis/Hemostasis.  29 (2023)  - p. 107602962311524 , 2023
Link: https://doi.org/10.1177/..
 
?
11

Medicare characteristics, treatment, cost and survival in t..:

Hlavacek, Patrick ; Schepart, Alex ; Silverstein, Alison R...
Future Oncology.  19 (2023)  11 - p. 775-787 , 2023
Link: https://doi.org/10.2217/..
 
?
12

P933: INDIRECT TREATMENT COMPARISON OF ELRANATAMAB WITH BEL..:

Mol, Isha ; Hu, Yannan ; Cappelleri, Joseph...
HemaSphere.  7 (2023)  S3 - p. e731126c , 2023
Link: https://doi.org/10.1097/..
 
?
13

P-250 The relationship of extramedullary disease and high-r..:

Meche, Aster ; Rondeau, Felix ; Vekeman, Francis...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S173-S174 , 2023
Link: https://doi.org/10.1016/..
 
?
14

P924: TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) M..:

Goyal, Ravi K ; Frugier, Gaelle ; Rombi, Julien...
HemaSphere.  7 (2023)  S3 - p. e40043b8 , 2023
Link: https://doi.org/10.1097/..
 
?
15

P-298 Retrospective study of treatment patterns and clinica..:

Meche, Aster ; Rondeau, Felix ; Gallienne, Samy...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S202 , 2023
Link: https://doi.org/10.1016/..
 
1-15